Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.80%
#2 Movement Movement +11.34%
#3 Victoria VR Victoria VR +7.37%
#4 DMT-NAT DMT-NAT +5.95%
#5 Cryptopia Cryptopia +5.23%
#6 COTI COTI +4.96%
#7 Lisk Lisk +4.73%
#8 Pons Pons +4.67%
#9 MarsCoin MarsCoin +4.33%
#10 Jito Jito +3.85%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Xeno Transplants Corporation Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
Rank in Stocks #42146
Xeno Transplants Corporation functions as a biotechnology firm dedicated to... Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$4.04K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CA
Trade Xeno Transplants Corporation (XENO)

Category

Healthcare
Stock price history for Xeno Transplants Corporation (XENO)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $0.33 on 2006-08-01
Stock price history of Xeno Transplants Corporation from 2006 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -50.00%
2022 100.00%
2021 -93.74%
2020 -73.43%
2019 102.25%
2018 -7.07%
2017 67.54%
2016 -45.43%
2015 153.29%
2014 -23.64%
2013 -9.52%
2012 -44.74%
2011 -59.79%
2010 332.31%
2009 -85.91%
2008 -96.85%
2007 -72.30%
2006 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -7.16%
KR